Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Qualigen Therapeutics, Inc. (QLGN) had Free Cash Flow per Share of $-1.60 for the most recently reported fiscal quarter, ending 2025-06-30.
Income Statement Financials | |
-- |
|
$-1.69M |
|
-- |
|
-- |
|
$1.68M |
|
$-1.68M |
|
$-0.00M |
|
$-1.69M |
|
$-1.69M |
|
$-1.69M |
|
$-1.69M |
|
$-1.69M |
|
$-1.69M |
|
$-1.68M |
|
$-1.58M |
|
1.68M |
|
1.68M |
|
$-1.00 |
|
$-1.00 |
|
Balance Sheet Financials | |
$3.96M |
|
-- |
|
$0.00M |
|
$3.96M |
|
$5.62M |
|
-- |
|
-- |
|
$5.62M |
|
$-4.44M |
|
$-1.65M |
|
$-1.65M |
|
1.64M |
|
Cash Flow Statement Financials | |
$-2.69M |
|
$-1.52M |
|
$3.36M |
|
$1.17M |
|
$0.33M |
|
$-0.84M |
|
$0.00M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
0.71 |
|
-- |
|
-- |
|
-- |
|
-2.19 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.69M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
37.94% |
|
102.01% |
|
-42.53% |
|
102.01% |
|
$-1.01 |
|
Free Cash Flow per Share |
$-1.60 |
$-1.60 |